(
out of
369
reviews
)
Clinical Locations
Primary Location
Huntsman Cancer Institute - Cancer Research North
Clinic 2D/E, BMT/Hematology
2000 Circle of Hope
Salt Lake City
,
UT
84112
VA - Building #14
Hematology/Oncology
500 S Foothill Dr
Salt Lake City
,
UT
84148
Board Certification
|
American Board of Internal Medicine (Internal Medicine)
|
Patient Rating
Patients consistently praise Dr. Tashi for his deep expertise and thorough, clear explanations of diagnoses, labs, and treatment options. Commenters emphasize that he listens well, includes patients in decisions, and provides compassionate, reassuring care while advocating to secure necessary medications. Many also highlight his supportive, professional team and say his communication and follow-up make them feel confident and at ease.
Generated via Patient Reviews
4.9
/5
( out of
369 reviews
)
The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers. The scale on which responses are measured is 1 to 5 with 5 being the best score.
Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.
Board Certification and Academic Information
| Academic Departments |
Internal Medicine
-Associate Professor (Clinical) |
|---|---|
| Academic Divisions |
Hematology & Hematologic Malignancies
|
| Board Certification |
American Board of Internal Medicine (Internal Medicine)
|
Education history
| Graduate Training | Master of Science in Clinical Investigation - University of Utah | M.S.C.I |
|---|---|---|
| Fellowship | Hematology/Oncology - University of Utah | Fellow |
| Residency | Internal Medicine - Creighton University | Resident |
| Residency | Internal Medicine - Pingtung Christian Hospital | Resident |
| Internship | Internal Medicine - MacKay Memorial Hospital | Intern |
| Professional Medical | Medicine - Chang Gung University School of Medicine | M.D. |
Selected Publications
Journal Article
- Reeves BN, El Chaer F, Foltz L, Tashi T, Abu-Zeinah G, Qin A, Lucas J, Halpern AB, Maze D, Safah H, OConnell CL, Goel S, Rein L, Fang B, How J, Babu S, Li Z, Cerquozzi S, Oh ST, Hunter AM, Podoltsev N, Vachhani P, Cunningham JM, Hillis C, Bose P, Yacoub A, Mascarenhas J, Zagrijtschuk O, Castro H, Mesa RA, Masarova L (2026). Ropeginterferon alfa-2b-njft treatment in essential thrombocythemia across different driver mutations: results from a North American, single-arm, multicentre study (EXCEED-ET). Lancet Reg Health Am, 61, 101529.
- Akin C, Sabato V, Gotlib J, Panse J, lvarez-Twose I, Radia DH, Livideanu CB, Jurcic J, Elberink HO, Van Daele P, Cerquozzi S, Dybedal I, Reiter A, Pongdee T, Barete S, Ustun C, Schafhausen P, Vadas P, Bose P, DeAngelo DJ, Rein L, Vachhani P, Triggiani M, Bonadonna P, Hartmann K, Broesby-Olsen S, Mattsson M, George TI, Shomali W, Giannetti M, Siebenhaar F, Lin HM, Bidollari I, Lampson B, Hong J, Doyle A, Tashi T, Castells M (2026). Avapritinib achieves long-term disease control with favorable safety in patients with indolent systemic mastocytosis over 3 years. J Allergy Clin Immunol.
- Tashi T, Shih LY, Yo YT, Sullivan A, Chueh HY, Kuo MC, Smith A, Kim SJ, Parsegov B, Reeves BN, Song J, Prchal JT (2026). Ropeginterferon alfa-2b has minimal transplacental passage and breastmilk secretion in pregnant MPN patients. Blood Adv, 10(7), 2168-2172.
- Reeves BN, Song J, Leier A, Smith A, Kim SJ, Chen SL, Tashi T, Prchal JT (2025). Metformin alleviates side effects and supports the resumption of interferon therapy in polycythemia vera and essential thrombocythemia. Haematologica.
- Mesa R, Gill H, Zhang L, Jin J, Kirito K, Komatsu N, Qin A, Xiao Z, Tashi T, Shimoda K, Ohishi K, Chen S, Zuo X, Shirane S, Hu Y, Zhang S, Wang Y, Takenaka K, Ichii M, Xu N, Shih LY, Lim KH, Lee SE, Bae SH, Teo WZY, Maze D, Oh ST, Bose P, Sato T, Zagrijtschuk O, Lin S, Shih WJ, Mascarenhas J, Masarova L, SURPASS-ET Study Group (2025). Ropeginterferon alfa-2b in hydroxyurea-intolerant or hydroxyurea-refractory essential thrombocythaemia (SURPASS ET): a multicentre, open-label, randomised, active-controlled, phase 3 study. Lancet Haematol, 12(11), e862-e875.
- Bose P, Nagler E, Nawaz MS, Rampal RK, Tashi T, Thota S, Mascarenhas JO (2025). Results from a US modified Delphi consensus to define disease progression and disease modification in polycythemia Vera. Ann Hematol, 104(10), 5063-5075.
- Madigan LM, Boggs NA, Rets AV, Gru AA, Tashi T, Wada DA, Florell SR, Carter MC (2025). Mastocytosis in the Skin: Approach to Diagnosis, Evaluation, and Management in Adult and Pediatric Patients. Am J Clin Dermatol, 26(4), 499-510.
- Masarova L, Reeves BN, El Chaer F, Foltz L, Tashi T, Abu-Zeinah G, Lucas J, Halpern AB, Maze D, Qin A, Safah H, Lan F, OConnell CL, Goel S, Rein L, Fang B, How J, Babu S, Li Z, Cerquozzi S, Oh ST, Hunter AM, Podoltsev N, Vachhani P, Yacoub A, Cunningham JM, Hillis C, Otoukesh S, Zagrijtschuk O, Castro H, Bose P (2025). A multicenter study to assess efficacy, safety, and tolerability of ropeginterferon alfa-2b-njft in patients with essential thrombocythemia in the US and Canada: EXCEED-ET trial. Front Med (Lausanne), 12, 1548590.
- Mascarenhas J, Bose P, Hillis C, Yacoub A, El Chaer F, Maze D, Abu-Zeinah G, Qin A, Priego V, Tashi T, Cerquozzi S, Babu S, Foltz L, Goel S, Bhave RR, Lee S, Oh ST, Reeves B, Benton C, Fletcher L, Sirhan S, Safah H, Salib H, Villeneuve PJA, Zagrijtschuk O, Castro H, Masarova L (2025). ECLIPSE-PV: A Randomized, Multicenter Study to Assess Efficacy, Safety, and Tolerability of Two Dosing Regimens of Ropeginterferon Alfa-2b-Njft in Polycythemia Vera. Acta Haematol, 1-7.
- Yacoub A, Abu-Zeinah G, Qin A, Tashi T, Dana W, Shih WJ, Zagrijtschuk O, Tsai CY, Geller R, Komatsu N, Mesa R, Gill H (2025). PARADIGM-PV: a randomized, multicenter phase 4 study to assess the efficacy and safety of ropeginterferon alfa-2b in patients with low- or high-risk polycythemia vera. Ann Hematol.
- Li P, Alnoor FNU, Xie W, Williams M, Feusier J, Ding Y, Zhao X, Zheng G, Zhao C, Zieske AW, Zu Y, Raess PW, Tantravahi S, Osman A, Patel AB, Tashi T, Patel JL, Matynia AP, Menon MP, Miles RR, Jacobsen JR, George TI, Sborov DW, Szankasi P, Rindler P, Close D, Ohgami RS (2024). Rapid growth of acquired UBA1 mutations predisposes male patients to low-risk MDS. Leukemia, 39(1), 248-256.
- Gotlib J, Castells M, Elberink HO, Siebenhaar F, Hartmann K, Broesby-Olsen S, George TI, Panse J, Alvarez-Twose I, Radia DH, Tashi T, Bulai Livideanu C, Sabato V, Heaney M, Van Daele P, Cerquozzi S, Dybedal I, Reiter A, Pongdee T, Barete S, Ustun C, Schwartz L, Ward BR, Schafhausen P, Vadas P, Bose P, DeAngelo DJ, Rein L, Vachhani P, Triggiani M, Bonadonna P, Rafferty M, Butt NM, Oh ST, Wortmann F, Ungerstedt J, Guilarte M, Taparia M, Kuykendall AT, Arana Yi C, Ogbogu P, Gaudy-Marqueste C, Mattsson M, Shomali W, Giannetti MP, Bidollari I, Lin HM, Sulllivan E, Mar B, Scherber R, Roche M, Akin C, Maurer M (2023). Avapritinib versus Placebo in Indolent Systemic Mastocytosis. NEJM Evid, 2(6), EVIDoa2200339.
- Tashi T, Yu J, Pandya S, Dieyi C, Scherber R, Parasuraman S (2023). Trends in overall mortality among US veterans with primary myelofibrosis. BMC Cancer, 23(1), 48.
- Chuah YY, Tashi T, Kuo CJ (2022). An unexpected cause of Cullen's sign: rupture of hepatocellular carcinoma. Br J Hosp Med (Lond), 83(11), 1.
- Feusier JE, Arunachalam S, Tashi T, Baker MJ, VanSant-Webb C, Ferdig A, Welm BE, Rodriguez-Flores JL, Ours C, Jorde LB, Prchal JT, Mason CC (2021). Large-Scale Identification of Clonal Hematopoiesis and Mutations Recurrent in Blood Cancers. Blood Cancer Discov, 2(3), 226-237.
- Gangaraju R, Song J, Kim SJ, Tashi T, Reeves BN, Sundar KM, Thiagarajan P, Prchal JT (2019). Thrombotic, inflammatory, and HIF-regulated genes and thrombosis risk in polycythemia vera and essential thrombocythemia. Blood Adv, 4(6), 1115-1130.
Review
- Bose P, Xiao Z, Hasselbalch HC, Prchal JT, Duan M, Yacoub A, Rampal R, Kiladjian JJ, Hobbs GS, Tashi T, Shimoda K, Kirito K, Gill H, Hou HA, Lee SE, Huang J, Li B, Qin A, Yu LH, Mascarenhas JO, Mesa RA (2025). Highlights from MPN Asia 2025: Advances in Molecular Pathogenesis and Therapeutic Strategies in Myeloproliferative Neoplasms. [Review]. Curr Hematol Malig Rep, 20(1), 9.
- Tashi T, Deininger MW (2023). Management of Advanced Systemic Mastocytosis and Associated Myeloid Neoplasms. [Review]. Immunol Allergy Clin North Am, 43(4), 723-741.
- Tashi T (2022). Hematocrit, White Blood Cells, and Thrombotic Events in the Veteran Population With Polycythemia Vera. [Review]. Fed Pract, 39(Suppl 2), S43-S46.
Book Chapter
- Tantravahi S, Tashi T, Prchal JT (2026). Primary Myelofibrosis (Chapter 87). In Kenneth Kaushansky, Josef T. Prchal, Marcel M. Levi, Irene Roberts, Swee Lay Thein, Thomas J. Kipps (Eds.), Williams Hematology, 11th edition (11th Edition). McGraw Hill.
Case Report
- Chuah YY, Tashi T, Lee YY, Fu TY, Shih CA (2020). Enteropathy-associated T-cell Lymphoma (EATL) with intracranial metastasis : a rare and dismal condition. Acta Gastroenterol Belg, 83(1), 77-80.
Editorial
- Song J, Tashi T, Prchal JT (2019). Editorial Comment on: Inhibition of Suicidal Erythrocyte Death by Chronic Hypoxia by Tang et al. (From: Tang F, Feng L, Li R, Wang W, Liu H, Yang Q, Ge R-L. High Alt Med Biol 2019;20:112-119; DOI: 10.1089/ham.2017.0159). High Alt Med Biol, 20(2), 120-121.
Letter
- Mesa R, Yacoub A, Tashi T, Chai-Ho W, Yoon CH, Mascarenhas J (2025). Navigating the peginterferon Alfa-2a shortage: practical guidance on transitioning patients to ropeginterferon alfa-2b. [Letter to the editor]. Ann Hematol, 104(4), 2571-2573.
Other
- Madigan LM, Boggs NA, Rets AV, Gru AA, Tashi T, Wada DA, Florell SR, Carter MC (2025). Correction to: Mastocytosis in the Skin: Approach to Diagnosis, Evaluation, and Management in Adult and Pediatric Patients. Am J Clin Dermatol (26(5), p. 851). New Zealand.
Cannot get better treatment and attention. Compassionate, genuine, professional and personal. The best.
Appreciate the care he has given to me. The medicine has given me extra time living with this deadly disease
Good doctor I have full confidence in him
True genius for certain. I have never liked a doctor more nor have I ever had a doctor be as supportive as Doctor Tashi. His caring shows. He has assembled a team with similar values. I feel it a real privilege to call him my doctor.
I feel most fortunate to have Dr Tashi's care and I appreciate the skilled staff that assist with my treatments.
Dr Tashi is thorough, converses with me about all issues pertaining to my diagnosis, he listens to my concerns and includes me in discussions and decisions moving forward. I trust him with my life!
An extraordinary professional. [TRANSLATED]
He's awesome! He knows a lot & he's likable.
True expertise from enormous experience in the field
DR.TASHI OUTSTANDING MORE THAN 10 PLUS
Great Doctor explains situation well and answers all questions you ask
Dr Tashi always takes this time to talk to me and make sure I understand all of my options. He's very kind and understanding.
Excellent physician.
He's very informative, caring and thorough,
Dr.Tashi explains the situation so a lai person can understand very well. He is caring, just a wonderful doctor!
Outstanding physician, expert in his field.
He is excellent when you get him on your appointment without a assistant doctor you don't expect
If you are fortunate enough to be treated by Dr. Tashi and his group you are in for a great experience from a heartfelt group of professionals. Dr. Tashi is brilliant!
Highly qualified professional in his field who treats his patients with great familiarity. [TRANSLATED]
Dr Tashi not only cares for his patients, he cares about them. He considers your life wants as well as your medical needs, and helps you to meet both as you travel your health journey. He answers any questions with thoughtful care, and when you have worries regarding your health, he listens and responds with compassion. I would recommend him to any patient who needs his professional help. He will help, or find help for your specific need.
Dr. Tashi is a wonderful doctor. He has great expertise and understanding.
Very pleased with following up with care and medication
I drive 3 1/2 hours to see Dr Tashi and it's well worth the travel.
Dr. Tashi is compassionate and caring; he took the time to listen to my concerns and explain the science and medicine behind my cancer. I feel very confident that I'm in great hands under his care.
Dr Tasewang, Is a great Dr. He listened and explained thing extremely well. He let me tape the conversation, I don't remember very well. I really appreciated that. Thank You Dr. Tashi
Dr. Tashi has done a great job of managing my lymphoma! His treatment plan has and is working perfectly and he makes me feel at ease with my condition.
Caring and thoughtful
Highly Recommend
Dr Tashi is a God send to me. He listens, educates, explains and never makes me feel like he is in a hurry. He is present in thought and is always including me in the discussion of my best treatment plans.
Dr Tashi cares very much for his patients and has been a rock-solid advocate for my health-care journey. He has not just taken an interest in my medical needs, but takes the time to work with and for me to accomodate my schedule needs. I appreciate most that he treats me with compassion and reassurance, and hears my concerns, answering with honest answers even if they may be hard for me to hear. I'm so grateful to be his patient.
Tashi is a wonderful doctor charismatic and respectful. Highly informative
Dr. Tashi is very experienced, thorough, and informative. He truly makes you feel at ease. He's an expert in his area of expertise
The personal and professional treatment I received from Dr Tashi got me the new medication I needed for treatment of my PV cancer. He went above and beyond to secure this medication for me. Thank you Dr Tashi.
He is so reassuring and informs me of everything. He explains my labs the shows me comparisons. He's the best!
Straightforward and caring, knowing exactly how to treat my diagnosis.
I am grateful to have Dr. Tashi as my doctor for my rare condition. He is exceptionally bright and explains things so that I can understand. He is caring and has humor. All things I need to deal with this condition.
Good doctor explained and answered any questions
Very knowledgeable and takes the time to cover all aspects of your disease and treatment options.
Dr. Fashion makes me feel heard. He listens to my concerns and I feel I have a say in my treatment.
It was obvious from the first day Dr. Tashi knew my disease and what we could do about it.